Sera Prognostics falls on stock offering news

Sera Prognostics

10/02/2025 21:32

** Sera Prognostics Inc's  SERA.O  down 7.6% in extended trading
to $4.11 as it looks to raise equity
** Salt Lake City-based women's health co commences offering
comprising stock and pre-funded warrants without disclosing deal
size
    ** Co says plans to use net offering proceeds to expand
commercial infrastructure in the U.S., accelerate preparations
for expansion in the European Union, fund additional studies to
increase adoption of its blood test to predict preterm birth
risks, PreTRM, including a potential submission to U.S. FDA for
broad approval
    ** Jefferies, TD Cowen and William Blair jt bookrunners for
offering, joined by RBC
    ** Co has ~33.77 mln shares outstanding giving it a current
market cap of ~$150 mln, per LSEG
    ** SERA shares on Mon closed down 2% at $4.45, extending YTD
decline to 45%
     

(Lance Tupper is a Reuters market analyst. The views expressed
are his own)
((lance.tupper@tr.com 1-646-279-6380))